×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cytori launches next-gen Celution cell therapy tech
Drug Delivery Business
CYTX shares were trading at $1.04 in mid-morning activity today, up 4%. Filed Under: Drug-Device Combinations, Featured...
83 months ago
Cytori CFO Resigns, Biotech Restructures In Bid To Focus Resources On Lung Cancer Drug
Yahoo Finance
Cytori said in an filing with the SEC that CFO Gary Titus notified the company of his intention to resign from his position effective...
58 months ago
Cytori stock rises on data for erectile dysfunction cell therapy
Fierce Biotech
Cytori stock rises on data for erectile dysfunction cell therapy ... A one-off injection of stem cells into the penis has restored erectile...
70 months ago
Phase 3 Trial of Cytori's Cell Therapy Completes 48-week Follow-up Visits
Raynaud News
Follow-up visits are complete in a Phase 3 trial of Cytori's Habeo cell therapy for hand scleroderma, which also helps reduce Raynaud's...
83 months ago
Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient
Lung Disease News
Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient ... In News, Scleroderma. ... Cell therapy company Cytori Therapeutics announced...
96 months ago
Cytori Divests Puregraft® Products, Licenses Celution® for Alopecia and Options Broader Aesthetic Market Rights
Business Wire
Cytori Therapeutics has entered into a $15 million three-part agreement with Bimini Technologies and its affiliates, Puregraft Technologies...
129 months ago
Cytori raises $6 million to fund stem cell trials
San Diego Union-Tribune
Cytori Therapeutics said it raised $6 million from a 1.3 million-share stock purchase agreement with East Coast-based Seaside 88 to fund...
154 months ago
Lorem Vascular Licenses Cytori Cell Therapy for Asia-Pacific in Up to $531M Deal
Genetic Engineering and Biotechnology News
Lorem Vascular will pay Cytori $31 million up front, and up to $500 million as licensing fees tied to achieving undisclosed revenue milestones...
126 months ago
What Cytori Therapeutics Isn't Telling Investors About Its Asian Partner
TheStreet
Lorem Vascular is a brand new company set up less than two weeks ago by a Malaysian real estate developer, Kian Thiam "K.T." Lim, according to...
126 months ago
A Conversation With Christopher J. Calhoun, CEO of Cytori Therapeutics
The Atlantic
As CEO Christopher J. Calhoun explains, the company aims to do nothing less than revolutionize health care by leading the way into an era of...
157 months ago